EMJ Podcast: Insights For Healthcare Professionals

In the final episode, Pranav Garimella explores glomerular and cystic kidney diseases, including IgA nephropathy and autosomal dominant polycystic kidney disease. Discover how personalised medicine, biomarkers, and earlier diagnosis are shaping the future of care in these complex conditions.

Timestamps:

01:11 – Current treatment for IgA nephropathy

02:24 – SGLT2 inhibitors

03:38 – Cystic kidney disease diagnosis

In Part 2, Pranav Garimella discusses major advances in diabetic kidney disease management. Learn how sodium-glucose cotransporter 2 (SGLT2) inhibitors and novel therapies are reshaping disease progression, and why early intervention is critical to improving long-term outcomes.

Timestamps:

01:07 – Practice-changing developments

05:10 – GLP-1 agonists

07:00 – Early intervention

08:43 – Unmet needs

Pranav Garimella joins host Catherine Glass to explore why early detection of chronic kidney disease remains challenging. From high-risk populations to emerging plasma and urine biomarkers, this episode examines how earlier diagnosis and improved risk stratification can transform patient outcomes.

Timestamps:

00:59 – Challenges of early detection

05:12 – Populations for intensive screening

09:08 – Plasma and urine biomarkers

13:45 – Biomarker-driven risk stratification

In this rapid-fire episode, Pranav Garimella answers key questions on chronic kidney disease, from early detection and screening challenges to future innovations in nephrology. A concise overview for clinicians and curious listeners alike.

In the final episode, Nanette K. Wenger discusses the ongoing challenges in awareness and access to cardiovascular care for women. From public health campaigns to mentorship and community initiatives, discover what's needed to close the gap.

Timestamps:

1:02 – Barriers in care

2:54 – Future directions

6:11 – Atlanta Women's Network

In Part 2, Nanette K. Wenger examines how underrepresentation in research shaped cardiovascular epidemiology in women. Learn about the impact of key guideline developments, and where critical data gaps remain.

Timestamps:

1:09 – Historical underrepresentation

5:05 – Evidence gaps

In this episode of Hema Now, Cynthia Dunbar discusses her pioneering career in translational stem cell biology. From the evolution of haematopoietic stem cell research to the clinical milestones that have propelled gene therapy into mainstream haematology, Dunbar shares insights on innovation, collaboration, and the future of patient care.

Timestamps:

00:00 - Introduction

01:35 - Origins in haematology research path

02:52 - Evolution of haematopoietic stem cell biology

06:35 - Milestones enabling gene therapy adoption

10:37 - Advances in bone marrow failure treatment

19:24 - Promise of natural killer (NK) cell therapies

24:09 - COVID-19 collaboration and crisis lessons

29:27 - Challenges in translational research pipeline

33:23 - Future breakthroughs transforming patient care

38:39 - Three wishes for research future

Nanette K. Wenger joins host Saranya Ravindran to reflect on her pioneering work in women's cardiovascular health. From challenging early misconceptions to advocating for inclusion in research, this episode explores how the field began to shift.

Timestamps:

0:58 – Nanette's inspiration

5:21 – Dismantling misconceptions

8:12 – Research obstacles

14:20 – Risk factors

In this rapid-fire episode, Nanette K. Wenger answers key questions on women's heart health - from prevention and lifestyle to mentorship, research gaps, and the future of cardiology. A concise, expert-led overview of the field.

In this episode of Onc Now, Christopher Wolfgang shares insights into the evolving landscape of pancreatic cancer research and treatment. From his early inspiration in oncology to pioneering surgical approaches and tackling tumour recurrence, Wolfgang discusses the challenges that persist in this complex disease space and the innovations shaping its future.

Timestamps:

00:00 – Introduction

01:28 - Career inspiration

03:24 – Impact of early training

05:00 - Advances in treatment

09:20 - Tumour recurrence research

11:25 - Surgical innovation impact

17:00 - Barriers to progress

20:24 - Future priorities

26:40 - Three healthcare wishes